Clinical Trial Update: DASH After TBI Study: Decreasing Adrenergic or Sympathetic Hyperactivity After Traumatic Brain Injury [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a DASH intervention to decrease adrenergic or sympathetic hyperactivity after traumatic brain injury. Results were posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Traumatic Brain Injury

Snippet

Sponsor: Vanderbilt University | Conditions: Brain Injuries, Craniocerebral Trauma | Phase 2 | Status: COMPLETED | Results posted: 2017-06-08